Official Gazette Notification Text
Official TranscriptGOVERNMENT OF INDIA MINISTRY OF AYUSH LOK SABHA STARRED QUESTION NO. 193 TO BE ANSWERED ON 31.07.2026 Research and Development Projects under AYURGYAN Scheme *193. Shri Ravindra Shukla Alias Ravi Kishan: Dr. Sanjay Jaiswal: Will the Minister of AYUSH be pleased to state: (a) the details of the progress of the 16 ongoing Research and Development (R&D) projects under the AYURGYAN Scheme in the...
GOVERNMENT OF INDIA MINISTRY OF AYUSH LOK SABHA STARRED QUESTION NO. 193 TO BE ANSWERED ON 31.07.2026 Research and Development Projects under AYURGYAN Scheme *193. Shri Ravindra Shukla Alias Ravi Kishan:
Dr. Sanjay Jaiswal:
Will the Minister of AYUSH
be pleased to state:
(a) the details of the progress of the 16 ongoing Research and Development (R&D) projects under the AYURGYAN Scheme in the country, State/UT-wise, including Odisha, particularly in the Keonjhar Parliamentary constituency;
(b) the details of the operational status of the Ayurveda Biology Integrated Health Research
(ABIHR) component;
(c) the details and the projected timeline for setting up the three new All lndia Institutes of Ayurveda (AllAs) announced in the Union Budget 2026; and
(d) the steps taken by the Government to strengthen research, education and healthcare infrastructure for the promotion and integration of Ayurveda through these initiatives? ANSWER THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYUSH (SHRI PRATAPRAO JADHAV)
(a) to (d) A Statement is laid on the table of the House.The Statement referred in reply to Lok Sabha Starred question no. 193 for 31.07.2026
(a) & (b) The Ministry of Ayush is implementing a Central Sector Scheme namely Ayurgyan since 2021-22 with the aim to support Research & Innovation in Ayush by providing Extra Mural Research activities and Education by providing academic activities, training, Capacity Building etc. The Scheme has 03 components viz. (i) Capacity Building & Continuing Medical Education (CME) in Ayush (ii) Research & Innovation (R&I) in Ayush from FY 2021-22 and (iii) Ayurveda Biology Integrated Health Research (ABIHR) was also added under the scheme as 3rd component in FY 2023-24.
Being the Central Sector Scheme, financial assistance is provided to the eligible institutions/organization across the country (including the state of Odisha) and the scheme is not specific to any State/UTs and regions .Under the Research & Innovation (R&I) in Ayush and Ayurveda Biology Integrated Health Research (ABIHR) components of the Ayurgyan Scheme, 34 and 11 research projects were supported respectively since inception of the scheme (i.e. 2021-22) for a duration of three years and funds were released on instalment basis. The details of the same is annexed at Annexure.
The outcomes of the research projects are in the forms of product development, patents, technology developed, SOPs, presentations on international platform, publication in reputed journals etc. The anticipated outcomes are realized upon completion of the projects. A total 82 research papers have been published in peer-reviewed journals under R&I component (including Erstwhile EMR) from FY 2021-22 to as on 30.06.2026. Further, under the R&I component of Ayurgyan Scheme, an amount of Rs.41.36 lakhs were released to National Institute of Technology, Rourkela, located in the state of Odisha, for conducting the research project.
(c) In pursuance of the announcement made in the recent Union Budget regarding the establishment of three new AIIAs, two committees namely, the Selection Committee and the Project Core Committee (PCC) have been constituted by the Ministry of Ayush for the purpose of site selection under the Challenge Method, issued by the Cabinet Secretariat.
(d) To strengthen integration of Ayurveda with basic sciences and the conventional system of medicine through high-end interdisciplinary research by promoting collaborative research between Ayush institutions and institutions engaged in modern biological sciences, ABIHR component of Ayurgyan Scheme has been implemented from 2023-24. Further, under Centre of Excellence component of Ayurswasthya Yojana, there is a provision for financial assistance for upgradation of infrastructure and integrative research activities.Ministry of Ayush is also implementing a Centrally Sponsored Scheme of National Ayush Mission (NAM) through State/UT Governments and supporting their efforts for overall development and promotion of Ayush systems of medicines including Ayurveda in the Country through State/UT Governments. The main objective of the scheme, inter-alia are as follows:
➢ Co-location of Ayush facilities at Primary Health Centres (PHCs), Community Health Centres (CHCs) and District Hospitals (DHs). ➢ Upgradation of existing standalone Government Ayush Hospitals. ➢ Setting up of up to 10/30/50 bedded integrated Ayush Hospitals.
➢ Establishment of new Ayush colleges in the States where availability of Ayush teaching institutions is inadequate in Government Sector. ➢ Infrastructural development of Ayush Under-Graduate Institutions and Ayush Post- Graduate Institutions/ add on PG/ Pharmacy /Para-Medical Courses.
Further, with regard to integration of Ayurveda, Government of India has adopted a strategy of Co-location of Ayush facilities at Primary Health Centres (PHCs), Community Health Centres (CHCs) and District Hospitals (DHs), thus enabling the choice to the patients for different systems of medicines under a single window.
In addition, Research Councils under Ministry of Ayush namely Central Council for Research in Ayurvedic Science (CCRAS), Central Council for Research in Homoeopathy
(CCRH), Central Council for Research in Unani Medicine (CCRUM), Central Council for Research in Siddha (CCRS) and Central Council for Research in Yoga & Naturopathy
(CCRYN) also undertake research activities such as Clinical Research, Drug Proving, Drug Verification, Drug validation, Drug Standardization, Public Health Research, Fundamental Research and Epidemic research through their Research Institutes/Treatment Centre/Peripheral Units. A total 693 no. of research studies (i.e. CCRAS-340, CCRH-142, CCRUM-140, CCRS-
71) were undertaken by the above Research Councils during FY 2025-26. ********Annexure
Details of Research Projects supported the various organizations under Ayurgyan Scheme:
Research & Innovation in Ayush Component S. ApprovedGr Grantee Institute Title of the Study Stream State N. ant (in Rs.) 2021-22
1. Institute Medical Clinical effect of Ayurvedic Ayurveda Uttar 948560 Sciences, Banaras formulation (withasomnifera, Pradesh Hindu University, Tinospora cordifolia Moringa Varanasi oleifera, Adhatoda vasica, Pipper longum, Glycyrrt glabra, ocimum sanctum and curcuma longa) in Covid-19 patients"
2. Govt. Siddha open labelled randomized case Siddha Tamil Nadu 999000 Medical College, control clinical study to evaluate the Palayamkottai, efficacy of vettummaarankuligai Tirunelvelli with Nilavembukudineer (VMK- NVK) in comparison with allopathic drug for the subjects affected with mild and moderate Covid-19
3. All India Institute Repurposing of Classical Ayurvedic Ayurveda Delhi 5355966 of Medical formulations for their anti-viral Sciences (AIIMS), effects on SARS-COV-2 Main
New Delhi Protease: A Pre-clinical in-vitro screening approach
4. Bangalore Medical An open-label controlled clinical Ayurveda Karnataka 1029000 College and study to evaluate the efficacy of Research Institute Sudarshana Churna, Yashtimadhu (BMC&RI), Churna, and Amritarishta as an add- Bengaluru on therapy to standard care in mild symptomatic COVID-19 positive patients 2022-23
1. International Centre Comparative and combined efficacy Siddha Delhi 6260020 for Genetic evaluation of extracts of Engineering and Nilavembukudineer and Biotechnology, vathasurakudineer New Delhi
2. All India Institute The effect of structured yoga Yoga & Delhi 6188936 of Medical practices on the quality of life and Naturopathy Sciences clinical outcomes in patients with ulcerative colitis
3. ICMR-National Health system preparedness of Siddha Tamil Nadu 3932388 Institute of Siddha system of medicine in Non- Epidemiology Communicable Diseases (NCDs), TNHB, Tamil Nadu: Current status, Ayappakkam, stakeholder perspectives and cost Chennai analysis4. Indian Institute of Effect of ghee from indigenous cow Ayurveda Tamil Nadu 7000000 Technology milk on cognition and neuro- Madras, Chennai protection against Alzheimer’s disease
5. All India Institute Randomized Controlled Trial on Ayurveda Delhi 3398861 of Medical effect of Indigenous Cows Ghrita Sciences and Jatyadi Ghrita on wound healing
6. All India Institute Management of Long COVID Yoga & Delhi 1239840 of Medical symptoms with Yoga based Naturo-pathy Sciences rehabilitation as an add on therapy to
the standard care: A randomised controlled trail 2023-24
1. Asthagiri Herbal Process standardization and Siddha Tamil Nadu 6874110 Research chemical characterization of a Foundation, siddha formulation, saara Chennai pathangam.
2. All India Institute Irnpact of yoga based lifestyle Yoga & Delhi 6107285 of Medical intervention on Polycystic Ovarian Naturo-pathy Sciences (AIIMS), Syndrome (PCOS) New Delhi
3. Central India Evaluation of Cow urine distillate as Ayurveda Maharashtra 4961608 Institute of Medical a bioenhancer to increase the Sciences (CIIMS), efficacy of anti-TB drugs against M.
N agpur tuberculosis infection
4. JSS Ayurveda A Comparative clinical study to Ayurveda Karnataka 5921869 Medical College & validate the influence of Gandha Hospital, Mysuru taila and Ksheerabala taila 101 on Osteopenia and Osteoporosis using biochemical markers of bone formation and resorption
5. Indian Institute of Molecular studies of Ayurveda Uttarakhand 6340274 Technology, pharmacologically active antiviral Roorkee molecules in Gau mutra distillate and drug extract against Chikungunya and Dengue
6. Savitribai Phule Exploring protective potential of Ayurveda Maharashtra 6471340 Pune University Dioscorea spp. In process of aging Pune and Alzheimer’s disease using Drosophila and rat animal models”
7. Maulana Azad A Randomized Clinical Controlled Ayurveda Delhi 6901960 Institute of Dental trial to evaluate the efficacy and Sciences safety of Ayurveda interventions in Chemo/Radiother apy induced Oral Mucositis in Oral Carcinoma
8. All India Institute Neuroprotective effect of medicinal Ayurveda Delhi 6145512 of Medical plants of Ayurveda in glauco vitro Sciences (AIIMS), mechanistic study” New Delhi9. School of Therapeutic evaluation of an unani Unani Tamil Nadu 5948796 Biosciences and herbal medicine against rheumatoid Technology, VIT arthritis (Wafa-ul-mafasil)-an University, Vellore immunological approach for scientific validation’’
10. Jamia Hamdard, Molecular mechanism of action of Unani Delhi 6206091 Hamdard Nagar, metalloid Unani Kushtajat for their New Delhi role in protection against cellular stress 2024-25
1. Kasturba Medical Exploration of physiological action Homoeo-pathy Karnataka 5405120 Collage, Manipal of homoeopathic anti-anxiety University,Manipal mediating human GABAergic and serotonergic neurons
2. National Institute of Gomutra Ark as a potent anti-cancer Ayurveda Odisha 5880780 Technology, agent for the treatment of Oral Rourkela SquamousCell Carcinoma - Molecular Mechanism underlying its anti-cancer effect
3. Dr. ALM Identifying the mechanism behind Unani Tamil Nadu 4604546 postgraduate the cardio-protective efficacy of Institute of Basic Bombyx mori (Abresham) on Medical Sciences, pressure overload induced cardiac University of hypertrophy and fibrosis An Madras, Chennai experimental study usingC57/BL mice
4. SDM College of Effect of Yoga on Endothelial Yoga & Karnataka 4236898 Medical Sciences & Function and Vascular Aging in Naturo-pathy Hospital, Dharwad Individuals with Type-2 Diabetes (Yoga V-Age): A Randomized Controlled Trial 2025-26
1. College of Pharmacological evaluation of Homoeo-pathy Kerala 5234697 Veterinary & homoeopathic drugs in breast cancer Animal Scciences cell lines
(CVAS), Mannuthy, Kerala Veterinary and Animal Sciences University, Wayanad
2. R. C. Patel Institute Investigation of molecular Homoeo-pathy Maharashtra 4419064 of Pharmaceutical evidences of anti-psoriatic efficacy Education and of selected homeopathic drugs using Research Shirpur, TLR-7/ IL-17/ IL-23 knock-in/out Dhule cell lines and mouse models of psoriasis
3. Interactive Effect of a therapeutic course of Ayurveda Maharashtra 5595230 Research School Basti on gut microbiome in obese for Health Affairs, individualsBharati Vidyapeeth, Pune
4. Vallabhbhai Patel A clinical study to evaluate the Ayurveda Delhi 5212550 Chest Institute, effects of yogic intervention on Delhi pulmonary functions, inflammatory markers, oxidative stress and health status in patients of Chronic Obstructive Pulmonary Disease
(COPD)
5. All India Institute Pre-clinical & Randomized Control Ayurveda Delhi 6159358 of Ayurveda Clinical Study to Evaluate the
(AIIA), New Delhi Effectiveness of Ayurvedic inhalation therapy (aerosol) and Rasayan therapy in the management of COPD
6. Post Graduate Mechanistic elucidation of Ayush- Ayurveda Chandigarh 5725252 Institute of Medical 56 in autism spectrum disorder like Education and animal model Research.
7. All India Institute Assessment of Unani Unani Delhi 6999480 of Medical Pharmacopoeial formulation (s) Sciences (AIIMS), adjuvant role along with antiseizure New Delhi medications in drug resistant
epilepsy: A combined experimental and clinical study approach
8. Jubilee Centre for Investigating Phenotypic-genotypic Ayurveda Kerala 6931880 Medical Research correlations of Ayurveda Prakriti Thrissur through a multidisciplinary approach
9. Sarada Krishna Evaluation of individualized Homoeo-pathy Tamil Nadu 7000000 Homoeopathic homoeopathic high dilution in the Medical College regression of cervical premalignant lesion of women in Kanniyakumari district
10. Jadavpur Pharmacological studies on the Unani West 6318930 University Kolkata probable mechanism of action of Bengal Modified Dawa-ul-Misk Motadil
(MDMM) in the management of cardiovascular diseases, involving formulation optimization of this ancient Unani preparation Total 17,79,55,201 (Rupees Seventeen Crore Seventy Nine Lakh Fifty Five Thousand Two Hundred One (17.79 Only) Crore) Ayurveda Biology Integrated Health Research Fund released during FY 2023-24 Sl. State Name of the Study Title Fund /UT Institution released No (In lakhs)1. Andhra Laila Development of Drug master file and technical dossier of 560.00 Pradesh Neutraceuticals Trigonella Foenum graecum-stage 1 (pre-clinical studies- Vijaywada oral toxicity genotoxicity, efficacy, pharmacokinetic studies and safety pharmacology in rodents)
2. Uttar Dabur Development of Technical dossier of Withania somnifera 56.00 Research –stage 2 (preclinical studies, oral toxicity, gebno toxicity, Pradesh foundation, efficacy, pharmaco kinetic studies and safety Ghaziabad pharmacology in rodents).
Total 616.00 Fund released during 2024-25 S. State /UT Name of the Study Title Fund Institution released N. (In Lakhs)
1. Maharashtra Intox Pvt. Ltd. Development of technical dossier of Boswellia serrate –stage 498.50 Pune 2 (preclinical studies–oral toxicity, genotoxicity, efficacy, pharmacokinetic studies and safety pharmacology in rodents)
2. Karnataka Adigyl Development of Technical dossier of Bacopa Monnieri – 499.32 Lifesciences stage 1 (preclinical studies-oral toxicity, genotoxicity, efficacy pharmacokinetic studies and safety pharmacology in Pvt. Ltd.
rodents)
3. Gujarat Jai Research Development of Technical dossier of Zingiber Officinale – 498.85 Foundation stage 1 (preclinical studies-oral toxicity, genotoxicity, Valvada efficacy, pharmacokinetic studies and safety pharmacology in rodents)
4. Andhra Laila Development of Drug master file and technical dossier of 499.54 Pradesh NeutraceuticalsTrigonella Foenum graecum-stage 1 (pre-clinical studies-oral , Vijaywada toxicity genotoxicity, efficacy, pharmacokinetic studies and safety pharmacology in rodents) Total 1996.21 Fund released during FY 2025-26 Sl. State /UT Name of the Study Title Fund Institution released No (In lakhs)
1. Uttar Dabur Research Development of Technical dossier of Withania 737.60 Pradesh foundation, somnifera–stage 1 (preclinical studies, oral toxicity, Ghaziabad genotoxicity, efficacy, pharmacokinetic studies and safety pharmacology in rodents)
2. Madhya Regional Ayurveda Preclinical Toxicological Evaluation and Safety 157.08 Pradesh Research Institute, Pharmacology of Selected Ayurvedic Formulations Aamkho, Gwalior, Triphala churna, Lashunadi vati, and Brihat Vata Madhya Pradesh Chintamani Rasa.
3. West Department of Toxicological Evaluation, Safety Assessment, and 548.33 Bengal Pharmaceutical Metabolomic Profiling of Selected Ayurvedic herbs Technology, Jadavpur and Formulations University, Kolkata
4. Karnataka Indian Institute I n v e s t i g a t i o n o f p o t e ntial leads from Ayurveda 472.00 of Science, Bangalore therapeutics for Management of AMR5. Maharashtra Regional Ayurveda Preclinical Toxicological Evaluation and Safety 236.64 Research Institute, Pharmacology of Selected Ayurvedic Formulations - Kothrud, Pune Laksha Guggulu, Dadimadi Ghrita and Ekangaveera Rasa
6. West Central Ayurveda Preclinical Toxicological Evaluation and Safety 339.10 Bengal Research Institute, Pharmacology of Rajah Pravartini Kolkata Vati, Phala Ghrita and Drakshavaleha Total 2490.40